| Literature DB >> 30410935 |
Xiaolong Ji1, Yingbin Shen2, Xudan Guo3.
Abstract
Polysaccharides obtained from Gynostemma pentaphyllum (Thunb.) Makino have promising prospects in functional food and nutraceuticals due to its broad range of biological activities including antioxidant, immunomodulatory, antitumor, hepatoprotective, neuroprotective, and antifatigue activities. These beneficial biological activities are related to chemical composition and structure of the G. pentaphyllum polysaccharides. The molecular weight, monosaccharide composition, and chemical structures could be influenced by both different extraction/purification techniques employed to obtain polysaccharide enriched products. The purpose of this article is to review previous and current literature regarding the extraction, purification, structural characterization, and biological activity of G. pentaphyllum polysaccharides. This review provides a useful bibliography for the further investigation, production, and application of G. pentaphyllum polysaccharides as functional foods and nutraceuticals.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30410935 PMCID: PMC6206586 DOI: 10.1155/2018/6285134
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
A summary of the extraction of polysaccharides from Gynostemma pentaphyllum.
| Types | Times (min) | Solid-liquid ratio | Temperature (°C) | Solvent | Other conditions | Yield (%) | References |
|---|---|---|---|---|---|---|---|
|
| |||||||
| GPMPP | 90 | 1:15 | 95 | water | 4 times | [ | |
| CGP | 15 | 1:67 | 95 | water | immersing time: 10 min | 11.29 | [ |
| CGP | 30 | 1:10 | 100 | water | 6.82 | [ | |
| CGP | 120 | 1:20 | 100 | water | 2 times | 6.35 | [ |
| CGP | 120 | 1:15 | 80 | water | 2.82 | [ | |
| CGP | 180 | 1:40 | 80 | water | 2 times | 5.35 | [ |
| CGP | 120 | 1:40 | 85 | water | 2 times | [ | |
| CGP | 120 | 1:15 | 90 | water | 2 times | 4.03 | [ |
| CGP | 60 | 1:16 | 80 | water | 9.66 | [ | |
| GPP | 120 | 1:15 | 80 | water | 2 times | 11.44 | [ |
| CGP | 120 | 1:16 | 80 | alkali solution | 0.5 M NaOH | [ | |
| CGP | 360 | 1:16 | alkali solution | 0.5 M NaOH | [ | ||
|
| |||||||
| CGP | 40 | 1:25 | water | ultrasonic power 900W 2 times | 7.29 | [ | |
| CGP | 31 | 1:26 | 83 | water | 3.356 | [ | |
| CGP | 15 | 50 | water | ultrasonic power 800W | 2.49 | [ | |
| GPP | 52 | 1:47 | 100 | water | ultrasonic power 129W | 3.24 | [ |
|
| |||||||
| CGP | 15 | 1:35 | water | microwave power 800W 2 times | 8.61 | [ | |
| CGP | 6 | 1:25 | microwave power 560W immersing time: 70 min | 3.91 | [ | ||
| GGP | 12 | 1:20 | microwave power 400W immersing time: 50 min | 3.37 | [ | ||
|
| |||||||
| CGP | 150 | 45 | water | ratio of enzyme amount 2%, pH 6.0 | [ | ||
Figure 1Schematic representation of the extraction, purification, and bioactivity of polysaccharides from the Gynostemma pentaphyllum.
The polysaccharides isolated from Gynostemma pentaphyllum.
| No. | Compound name | Molecular weight (Da) | Monosaccharide composition | Structures | Biological activities | Reference |
|---|---|---|---|---|---|---|
| 1 | GPMPP | 3.67×104 | Rha, Ara, Xyl, Man, Glc, Gal in the ratio of 1.39:3.76:1.00:1.64:4.98: | Antioxidant | [ | |
|
| ||||||
| 2 | GPA1 | 1.96×104 | Man, Rha, GlcA, GalA, Glc, Gal, Ara, Fuc in the ratio of 1:0.04:1.4: 0.9:1.3:2.6:2:0.2 | Antioxidant | [ | |
| GPA2 | 1.06×104 | Man, Rha, GlcA, GalA, Glc, Gal, Xyl, Ara, Fuc in the ratio of 1:0.1: 2.2:1.8:2.2:2.6:0.2:1.9:0.2 | ||||
| GPA3 | 6.7×103 | Man, Rha, GlcA, GalA, Glc, Gal, Xyl, Ara, Fuc in the ratio of 1:0.6: 3.9:0.5:5.5:2.6:0.5:1.2:0.2 | ||||
|
| ||||||
| 3 | GPP1 | Glc, Man, Gal, Rha, Ara in the ratio of10.0:9.9:5.1:2.5:2.4 | Backbone composed of (1→6)-linked- Glc | Neuroprotective effect | [ | |
|
| ||||||
| 4 | CGPP | Man, Glc, Ara, Rha, Gal, GlcA in the ratio of 2.0:2.2:1.3:2.2:1.2:2.5 | Anticancer | [ | ||
|
| ||||||
| 5 | GPP-TL | 9.3×103 | Glc, Gal, Ara in the ratio of 43:5:1 | Backbone composed of (1→4)- | Antioxidant | [ |
|
| ||||||
| 6 | GPS-3 | 9.1×103 | Rha, Xyl, Ara, Gal, Glc in the ratio of 1.75:1.00:8.70:3.07:5.79 |
| Hepatoprotective activity | [ |
| GPS-2 | 1.07×104 | Rha, Xyl in the ratio of 1:12.25 |
| |||
|
| ||||||
| 7 | GPP1-a | Ara, Gal, Glc in the ratio of 0.18: 0.72:1.00 |
| Antioxidant | [ | |
| GPP2-b | Ara, Rib, Xyl, Gal, Glc in the ratio of 0.38:0.64:0.97:1.26:1.00 |
| ||||
| GPP3-a | Rib, Fru, Gal, Glc in the ratio of 1.62:0.54:0.49:1.00 |
| ||||
|
| ||||||
| 8 | GP-I | 9.3×104 | Glc, Gal, Man, Rha, Ara in the ratio of 5.3: 4.2: 3.0: 0.7: 0.8 | Anticancer | [ | |
|
| ||||||
| 9 | GP-B1 | 7.9×104 | Gal, Ara, Man, Rha, Xyl, Glc, GalA, GlcA in the ratio of 3.5:3.2: 0.6:0.9:0.3:0.5:0.6:0.4 | Antitumor | [ | |
| GP-C1 | 1.26×105 | Gal, Ara, Man, Rha, Glc, GlcA in the ratio of 2.1:1.0:0.3:0.5:0.4:0.9 | ||||
|
| ||||||
| 10 | GPP2-s1 | 1.12×104 | C-6 position and C-2 position | Antitumor | [ | |
|
| ||||||
| 11 | GPP1-a | 8.92×104 | Ara, Gal, Glc in the ratio of 0.18:0.72:1.00 | Backbone composed of (1→4)- | Anti-fatigue activity | [ |
| GPP2-b | 1.975×105 | Ara, Rib, Xyl, Gal, Glc in the ratio of 0.38:0.64:0.97:1.26:1.00 |
| |||
| GPP3-a | 2.536×105 | Rib, Fru, Gal, Glc in the ratio of 1.62:0.54:0.49:1.00 |
| |||
|
| ||||||
| 12 | PSGP | Gal, Ara, Rha, GalA, Xyl, Man, GlcA in the ratio of 18.9: 10.5:7.7: 4.7:3.9:3.1:1.2 | Immunomodulation | [ | ||
|
| ||||||
| 13 | GPP-S | 1.2×106 | Rha, Ara, Glc, Gal in the ratio of 1:3.72:19.49:7.82 | Backbone composed of (1→4)-linked- Glc | Antioxidant | [ |
|
| ||||||
| 14 | GM | Glc, Gal, Man, Fru in the ratio of 1.54:3.05:1.00:1.10 | Antioxidant | [ | ||
| GMA | 9.4×104 | Glc, Fru in the ratio of 11.45:1.00 | ||||
| GMB | 1.2×105 | Glc, Gal, Man in the ratio of 1.30:1.31:1.00 | ||||
| GMC | 7.2×104 | Glc, Gal, Man, Fru in the ratio of 1.00:2.17:1.25:1.02 | ||||
|
| ||||||
| 15 | GPP | 7.1×103 | Man, Glc, Gal, Ara, in the ratio of 1.00:77.33:4.81:1.83. | Backbone composed of (1→4)- | Antioxidant | [ |
|
| ||||||
| 16 | GPM1 | 2.0×105 | Rha, Ara, Xyl, Man, Glc, Gal in the ratio of 1.78:1.99:1.00:1.11:6.00:6.89 | Antioxidant | [ | |
| GPM2 | 1.67×105 | Rha, Ara, Xyl, Man, Glc, Gal in the ratio of 3.23:7.70:1.00:2.29:2.88: 14.82 | ||||
|
| ||||||
| 17 | GPI | Glc, GalA, Man, Ara, Rha, Gal, Xyl in the ratio of 6.81:7.19:13.19: 33.86:6.77:8.13:3.46 | furan structure | Antioxidant | [ | |
|
| ||||||
| 18 | GPP | 2.52×106 | Man, GlcA, Gal, Xyl, Rha |
| Antioxidant | [ |
Figure 2Schematic structure of GPP1-a (a) and GPP-S (b).